AREV Life Sciences Global Corp. engages in the production and development of natural health and cannabis infused products. The company is headquartered in Coquitlam, British Columbia. The company produces ingredients and formulates therapeutic interventions in clinical nutrition, supplements, topicals and rational drug design, based on science. Its nutraceutical product formulations are sold under its BARE and Wright and Well brands. Its BARE and Wright and Well Brands of finished products include natural health products, including cannabidiol (CBD)-infused products such as Canna-Mulsion and NaturVax, an anti-viral supplement; NaturRelax, a natural Sleep Aid; Natur Relief, an anti-inflator and pain relief product, and a line of CBD skincare products and medicinal oils and edibles. Its Ready-to-Use Therapeutic Food (RUTF) for Severe Acute Malnutrition (SAM), with its branded RUTF known as SUS-TAINN (Superior Utility Supplementation Therapeutic Agent for Indicated Nutritional Needs), and RESTORE is under development.
根據最新的財務報表(Form-10K),AREV Life Sciences Global Corp. 的總資產為 $0,淨isProfitable}為 $-1
AREVF 的關鍵財務比率是什麼?
AREV Life Sciences Global Corp. 的流動比率為 0,淨利潤率為 0,每股銷售為 $0。
AREV Life Sciences Global Corp. 的收入按細分市場或地理位置如何劃分?
AREV Life Sciences Global Corp. 最大收入來源為 Business Aircraft - Manufacturing and Other,在最近的收益報告中收入為 9,014,347,455。就地區而言,United States 是 AREV Life Sciences Global Corp. 的主要市場,收入為 7,625,206,373。
AREV Life Sciences Global Corp. 是否盈利?
無,根據最新的財務報表,AREV Life Sciences Global Corp. 的淨損失為 $-1